Three-month sustained-release triptorelin (11.25 mg) in the treatment of central precocious puberty.
暂无分享,去创建一个
[1] J. Carel,et al. Precocious puberty and statural growth. , 2004, Human reproduction update.
[2] A. Schindler,et al. Equivalence of the 3-month and 28-day formulations of triptorelin with regard to achievement and maintenance of medical castration in women with endometriosis. , 2004, Fertility and sterility.
[3] H. Pinedo. The Role of VEGF in Oncology: Effects on Hemostasis and Thrombosis , 2003, Pathophysiology of Haemostasis and Thrombosis.
[4] C. Teinturier,et al. Treatment of central precocious puberty by subcutaneous injections of leuprorelin 3-month depot (11.25 mg). , 2002, The Journal of clinical endocrinology and metabolism.
[5] V. Tillmann,et al. Suppression of puberty with long‐acting goserelin (Zoladex‐LA): effect on gonadotrophin response to GnRH in the first treatment cycle , 2002, Clinical endocrinology.
[6] W. Sippell,et al. Treatment of central precocious puberty. , 2002, Best practice & research. Clinical endocrinology & metabolism.
[7] J. Carel,et al. Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. French study group of Decapeptyl in Precocious Puberty. , 1999, The Journal of clinical endocrinology and metabolism.
[8] D. Jacqmin,et al. Three-Month Sustained-Release Form of Triptorelin in Patients with Advanced Prostatic Adenocarcinoma: Results of an Open Pharmacodynamic and Pharmacokinetic Multicenter Study , 1998, Hormone Research in Paediatrics.
[9] J. Carel,et al. Treatment of central precocious puberty with depot leuprorelin. French Leuprorelin Trial Group. , 1995, European journal of endocrinology.
[10] S. Bernasconi,et al. Final height in girls with central precocious puberty: comparison of two different luteinizing hormone‐releasing hormone agonist treatments , 1994, Acta paediatrica.
[11] M. Craen,et al. Variations in pituitary—gonadal suppression during intranasal buserelin and intramuscular depot‐triptorelin therapy for central precocious puberty , 1994, Acta paediatrica.
[12] O. Pescovitz,et al. Local reactions to depot leuprolide therapy for central precocious puberty. , 1993, The Journal of pediatrics.
[13] R. Battini,et al. Growth velocity and serum aminoterminal propeptide of type III procollagen in precocious puberty during gonadotropin‐releasing hormone analogue treatment , 1993, Acta paediatrica.
[14] L. Bachrach,et al. Two-year results of treatment with depot leuprolide acetate for central precocious puberty. , 1992, The Journal of pediatrics.
[15] S. Rose,et al. Acta Paediatrica Scandinavica , 1991, Archives of disease in childhood.
[16] P. A. Lee,et al. Depot leuprolide acetate dosage for sexual precocity. , 1991, The Journal of clinical endocrinology and metabolism.
[17] W. Crowley,et al. Gonadotropin-releasing hormone and its analogues. , 1991, The New England journal of medicine.
[18] R. Odink,et al. Treatment of children with central precocious puberty by a slow-release gonadotropin-releasing hormone agonist , 1990, European Journal of Pediatrics.
[19] O. Pescovitz,et al. Resumption of puberty after long term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty. , 1988, The Journal of clinical endocrinology and metabolism.
[20] J. Chaussain,et al. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules. , 1986, The Journal of clinical endocrinology and metabolism.
[21] W. Crowley,et al. Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report. , 1981, The New England journal of medicine.
[22] W. Crowley,et al. Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty. , 1981, The Journal of clinical endocrinology and metabolism.
[23] M. Maresh,et al. Radiographic Atlas of Skeletal Development of the Hand and Wrist , 1950 .
[24] R. Odink,et al. Comparison of complete and incomplete suppression of pituitary-gonadal activity in girls with central precocious puberty: influence on growth and predicted final height. The German-Dutch Precocious Puberty Study Group. , 1993, Hormone research.
[25] R. Odink,et al. Long-term results with a slow-release gonadotrophin-releasing hormone agonist in central precocious puberty. Dutch-German Precocious Puberty Study Group. , 1991, Acta paediatrica Scandinavica. Supplement.
[26] R. Milsted,et al. Gonadotropin-releasing hormone and its analogues. , 1991, The New England journal of medicine.
[27] Z. Laron,et al. Pubertal development, growth and final height in girls with sexual precocity after therapy with the GnRH analogue D-TRP-6-LHRH. A report on 15 girls, followed after cessation of gonadotrophin suppressive therapy. , 1990, Hormone research.